Psycheceutical Bioscience, Inc. Announces Medical Advisory Board
18 oct. 2022 10h15 HE
|
Psycheceutical Bioscience, Inc.
MIAMI, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for...
Psycheceutical Bioscience, Inc.'s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council
04 oct. 2022 10h14 HE
|
Psycheceutical Bioscience, Inc.
MIAMI, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc. (“Psycheceutical” or the “Company”) (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for...
Psycheceutical Bioscience, Inc.'s CEO to Present at the Life Sciences Investor Forum on September 15
13 sept. 2022 11h15 HE
|
Psycheceutical Bioscience, Inc.
MIAMI, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc. ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for...
Psycheceutical Bioscience, Inc. Enters into Exclusive Option to Acquire Vici Health Sciences
16 août 2022 10h14 HE
|
Psycheceutical Bioscience, Inc.
MIAMI, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc. (“Psycheceutical” or the “Company”) (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for...
Mydecine Provides Company Update; Welcomes New Board Member
09 juin 2022 07h00 HE
|
Mydecine Innovations Group Inc.
DENVER, June 09, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the...
CATALYST Summit 2022 Returns to Highlight Psychedelic Medicine’s Growing Role in the Medical Industry, Business Innovation and Society
05 mai 2022 06h30 HE
|
CATALYST Presents Foundation
Kingston, Ontario, May 05, 2022 (GLOBE NEWSWIRE) -- CATALYST Presents Foundation (“CATALYST”), the producer of Canada's premiere series of psychedelic medicine conferences, hosts its third annual...
CATALYST Summit 2022 Returns to Highlight Psychedelic Medicine’s Growing Role in the Medical Industry, Business Innovation and Society
05 mai 2022 06h30 HE
|
CATALYST Presents Foundation
Kingston, Ontario, May 05, 2022 (GLOBE NEWSWIRE) -- CATALYST Presents Foundation (“CATALYST”), the producer of Canada's premiere series of psychedelic medicine conferences, hosts its third annual...
Microdose Psychedelic Insights to Host Psychedelic Capital: March 2022 Conference
10 mars 2022 09h35 HE
|
Microdose Psychedelic Insights
TORONTO, March 10, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Microdose Psychedelic Insights, the leading guide to the business of psychedelics will be hosting the upcoming Psychedelic Capital:...
Ketamine Media Launches Industry-Leading Psychedelic Therapy Network
03 févr. 2022 09h30 HE
|
Ketamine Media
KNOXVILLE, Tenn., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Ketamine Media (Keta Media, LLC) is proud to announce the launch of its Psychedelic Therapy Network (PTN), a digital ecosystem linking psychedelic...
IBN (InvestorBrandNetwork) and PsychedelicNewsWire to Further Collaborate with Microdose Psychedelic Insights for the Upcoming Wonderland Miami Conference
01 nov. 2021 09h35 HE
|
InvestorBrandNetwork (IBN)
NEW YORK, Nov. 01, 2021 (GLOBE NEWSWIRE) -- via PsychedelicNewsWire -- IBN (“InvestorBrandNetwork”), a multifaceted financial news and publishing company, today announces that it will be...